Enlipsium develops photoluminescent materials utilizing rare earth lanthanides to enhance medical diagnostics and solar energy applications. Their technology addresses the need for efficient light production in various industries, improving performance and sustainability.
Funding
$240K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current methods of dosimetry, used to regulate and measure ionizing energy in radiation therapies, can be inaccurate and time-intensive, potentially leading to under- or over-exposure of radiation to cancer patients. Traditional film dosimetry can require up to 12 hours for film development and depends on low-resolution imaging, hindering the creation and calibration of complex radiation therapy plans.
Solution
Enlipsium is developing advanced photoluminescent materials to improve the accuracy, quality, and speed of dosimetry in radiation therapy. Their solution uses luminescent materials that emit light when stimulated by energy to enhance the precision of radiation treatment. The technology enables dose mapping, providing doctors with precise radiation dose information at the pixel level, and delivers results in under 10 minutes, empowering medical physicists and oncologists with timely, actionable data for informed decisions about patient care. This rapid turnaround increases the number of patients that can be treated and reduces patient anxiety by minimizing delays in their treatment journey.
Target Audience
Enlipsium's primary customers are hospitals, oncologists, and medical physicists seeking to improve the accuracy and efficiency of radiation therapies for cancer patients.
Features
- Luminescent materials that emit light when stimulated by energy for enhanced radiation measurement.
- Dose mapping technology providing precise radiation dose information at the pixel level.
- Rapid results delivery in under 10 minutes for timely clinical decision-making.
- 3D dosimetry for precise volumetric dose readings.
- Real-time dose monitoring for immediate feedback during radiation therapy.
- Specialized dose measurements tailored for proton beam therapy.